Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
Fibroblast Growth Factor 19 (FGF19) neutralizing antibodies inhibit hepatocellular carcinoma (HCC) growth but have safety issues. Here, the authors show that FGF19 promotes HCC by activating STAT3 signalling via IL-6 production and that targeting IL-6 pathway abolishes FGF19-induced HCC without side...
Main Authors: | Mei Zhou, Hong Yang, R. Marc Learned, Hui Tian, Lei Ling |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms15433 |
Similar Items
-
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis
by: In Hye Jung, et al.
Published: (2015-07-01) -
FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis
by: José Ursic-Bedoya, et al.
Published: (2024-01-01) -
STIM1 Mediates Hypoxia-Driven Hepatocarcinogenesis via Interaction with HIF-1
by: Yongsheng Li, et al.
Published: (2015-07-01) -
Stat3/IL-6 signaling mediates sustained pneumonia induced by Agiostrongylus cantonensis.
by: Hongli Zhou, et al.
Published: (2022-05-01) -
Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling.
by: Anna Kakehashi, et al.
Published: (2014-01-01)